Immuneering Corporation IMRX
4.27
(0.07)
(1.61%)
as of 25 Sep
- Market cap
- $280.8M
- P/E
- 0.0×
Follow IMRX
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/S ratio |
— | — | — | 333.79 | 105.83 | 33.89 | 33.89 | — |
P/FCF ratio |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/Operating CF |
— | — | — | (9.01) | (23.82) | (13.54) | (13.54) | — |
P/B ratio |
— | — | — | 0.96 | 1.41 | 0.00 | 0.00 | — |
Price to Tangible BV |
— | — | — | 1.03 | 1.48 | 0.00 | 0.00 | — |
EV/Sales |
— | — | — | 0.91 | 34.10 | 14.35 | 14.35 | — |
EV/EBITDA |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
— | — | — | (0.01) | (2.30) | (1.72) | (1.72) | — |
EV/FCF |
— | — | — | (0.01) | (2.29) | (1.71) | (1.71) | — |
Quick Ratio |
17.16 | 4.82 | 10.92 | 13.10 | 26.53 | 16.66 | 27.69 | — |
Current Ratio |
17.50 | 5.28 | 11.35 | 13.50 | 27.04 | 16.73 | 27.83 | — |
Net Debt/EBITDA |
2.94 | 0.57 | 1.46 | 2.06 | 4.44 | 2.18 | (0.45) | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 117.64% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (2.54) | — |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.09 | 0.27 | — |
Operating CF/Net income |
0.81 | 0.90 | 0.92 | 0.87 | 0.92 | 0.86 | 0.58 | — |
Capex/Depreciation |
(0.26) | (0.19) | 1.35 | (1.19) | (0.21) | (0.67) | 0.00 | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (43.12%) | (92.51%) | (53.36%) | (38.00%) | (50.24%) | 117.48% | 53.15% | — | |
| (39.36%) | (78.61%) | (47.54%) | (34.95%) | (32.70%) | (64.86%) | (109.20%) | — | |
ROIC |
(81.29%) | (763.99%) | (743.47%) | (747.69%) | (312.34%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
(33.53%) | (183.81%) | (64.71%) | (49.49%) | (22.73%) | (47.95%) | (56.71%) | — |
Average Days of Receivables |
— | — | — | 14.28 | 43.17 | 78.97 | 39.91 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 11,440.73% | 1,276.01% | 649.09% | 222.27% | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 4,923.19% | 397.69% | 134.54% | 141.11% | — |
Intangible Assets out of Total Assets |
0.03 | 0.13 | 0.07 | 0.06 | 0.04 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 1,282.15% | 86.66% | 47.02% | 0.00% | — |
Graham Net Nets |
— | — | — | 0.91 | 0.64 | (0.42) | (0.42) | — |
Graham Number |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
— | — | — | (47.88%) | (23.24%) | (25.50%) | (25.50%) | — |
Free Cash Flow Yield |
— | — | — | (42.38%) | (14.04%) | (24.78%) | (24.78%) | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.01 | 0.15 | 0.47 | 0.08 | — |
Operating CF per Share |
(1.03) | (1.83) | (1.72) | (1.67) | (2.27) | (2.95) | (0.18) | — |
Capex per Share |
0.00 | 0.00 | (0.01) | (0.03) | 0.00 | (0.01) | 0.00 | — |
Free Cash Flow per Share |
(1.03) | (1.84) | (1.74) | (1.70) | (2.27) | (2.96) | (0.18) | — |
Cash per Share |
3.93 | 1.21 | 3.01 | 4.00 | 10.96 | 7.49 | 0.54 | — |
Shareholders Equity per Share |
4.96 | 1.38 | 3.19 | 4.16 | 11.46 | (4.54) | (0.26) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
4.96 | 1.38 | 3.19 | 4.16 | 11.46 | (4.54) | (0.26) | — |
Free Cash Flow |
(45.49) | (55.08) | (49.31) | (44.84) | (30.91) | (14.67) | (4.50) | — |
Working Capital |
166.17 | 32.08 | 81.24 | 100.69 | 146.70 | 35.48 | 13.56 | — |
Capital Expenditures |
(0.14) | (0.08) | (0.34) | (0.74) | (0.06) | (0.05) | (0.02) | — |
Net Current Asset Value |
162.75 | 28.26 | 77.08 | 96.23 | 141.61 | (23.17) | (6.59) | — |
EV/EBIT |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 2.34 | 0.03 | 0.02 | 0.00 | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | (15,934.89%) | (1,612.30%) | (737.18%) | (401.59%) | — |
Price to Operating Income |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.58 | 0.40 | (0.18) | 0.46 | 0.36 | 1.23 | 0.51 | — |
Cash ROIC |
(11.83%) | (72.39%) | (28.58%) | (21.11%) | (10.37%) | (100.52%) | (19.00%) | — |
Accounts Receivable Turnover |
— | — | — | 2.45 | 5.58 | 6.51 | 5.41 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.07 | 0.80 | 1.44 | 1.39 | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 7,282.92 | 441.35 | 422.07 | 87.16 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
— | — | — | 0.13 | 0.37 | 0.36 | 0.36 | — |
Average Payables |
1.75 | 2.04 | 2.63 | 2.27 | 1.44 | 0.89 | 0.89 | — |
Average Assets |
142.35 | 77.65 | 112.48 | 144.54 | 102.56 | 26.27 | 7.06 | — |
Average Common Equity |
129.94 | 65.98 | 100.21 | 132.92 | 66.75 | (14.50) | (14.50) | — |
Columns are period end dates